SCHEMBL7974837

SCHEMBL7974837

CCN(CC)S(=O)(=O)c1ccc([C]=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.66
HTT P42858 4/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM1A O60341 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
ALDH1A1 P00352 5/20 0.49
MAPT P10636 2/20 0.49
TSHR P16473 1/20 0.49
HPGD P15428 1/20 0.48
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8837613 0.83 LMNA (0.63) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL3636387 0.83 LMNA (0.63) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL20183917 0.81 LMNA (0.56) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL29566225 0.79 LMNA (0.58) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL23057256 0.78 LMNA (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL10592845 0.78 LMNA (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5023540 0.78 HTT (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5805726 0.78 LMNA (0.55) LMNAHTTSMN1; SMN2NPC1MEN1
SCHEMBL20183923 0.78 LMNA (0.56) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5024746 0.76 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271383-B1 USEFUL ACTIVITY AGAINST GRAM-POSITIVE PATHOGENS; IN PARTICULAR, AGAINST VARIOUS STRAINS EXHIBITING RESISTANCE TO VANCOMYCIN AND AGAINST E. FAECIUM STRAINS RESISTANT TO BOTH AMINOGLYCOSIDES AND CLINICALLY USED BETA-LACTAMS. ZENECA LIMITED (GB) 2001-08-07 US disclosed